Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2010

01-12-2010

Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey

Authors: Tung-Sung Tseng, Hui-Yi Lin, Michelle Y. Martin, Ted Chen, Edward E. Partridge

Published in: Journal of Cancer Survivorship | Issue 4/2010

Login to get access

Abstract

Introduction

Continued smoking after a cancer diagnosis is a critical problem. This study examined smoking prevalence among all and specific cancer survivors, and compared demographic profiles of the current smokers between cancer and non-cancer individuals.

Methods

We used data from 2,188 cancer survivors and 22,441 non-cancer individuals who participated in the 10-year National Health and Nutrition Examination Survey (NHANES 1999–2008). All analyses were weighted to represent the United States population.

Results

The current smoking rates decreased as age increased in both cancer and non-cancer populations. The smoking rate was higher in young cancer survivors (age <=40) than in young non-cancer individuals. The cervical, colon cancer and melanoma survivors had higher age-adjusted smoking rates than survivors of other cancers. For non-cancer individuals, the results showed that poorer white males with lower educational levels, with widowed, divorced, or separated marital status, who were underweight and had at least 12 alcoholic beverages a year, were more likely to be current smokers.

Discussions/conclusions

We can observe that age, race, education, marital status, and year since cancer diagnosis were important predictors of smoking status in cancer survivors based on the results of multivariable modeling and comparisons of age-adjusted smoking rates in specific cancer sub-groups. This implies that developing smoking cessation programs for cervical cancer and melanoma is of particularly high priority because survivors of these cancers had relatively high smoking rates and low quit smoking rates after diagnosis. These efforts should improve their quality of life and health status as well as reduce smoking-related health disparities.
Literature
1.
go back to reference Marshall L, Schooley M, Ryan H, Cox P, Easton A, Healton C, et al. Youth tobacco surveillance–United States, 2001–2002. MMWR Surveill Summ. 2006;55:1–56.PubMed Marshall L, Schooley M, Ryan H, Cox P, Easton A, Healton C, et al. Youth tobacco surveillance–United States, 2001–2002. MMWR Surveill Summ. 2006;55:1–56.PubMed
2.
go back to reference A Report of the Surgeon General. Executive summary. Tobacco use among U.S. racial/ethnic minority groups–African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. MMWR Recomm Rep. 1998;47:1–16. A Report of the Surgeon General. Executive summary. Tobacco use among U.S. racial/ethnic minority groups–African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. MMWR Recomm Rep. 1998;47:1–16.
3.
go back to reference American Cancer Society. Cancer Facts & Figures 2007. Atlanta: American Cancer Society; 2007. American Cancer Society. Cancer Facts & Figures 2007. Atlanta: American Cancer Society; 2007.
4.
go back to reference Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath Jr CW, et al. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer. 2002;87:1234–45.CrossRefPubMed Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath Jr CW, et al. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer. 2002;87:1234–45.CrossRefPubMed
5.
go back to reference Baron JA. Smoking and estrogen-related disease. Am J Epidemiol. 1984;119:9–22.PubMed Baron JA. Smoking and estrogen-related disease. Am J Epidemiol. 1984;119:9–22.PubMed
6.
go back to reference Fink AK, Lash TL. A null association between smoking during pregnancy and breast cancer using Massachusetts registry data (United States). Cancer Causes Control. 2003;14:497–503.CrossRefPubMed Fink AK, Lash TL. A null association between smoking during pregnancy and breast cancer using Massachusetts registry data (United States). Cancer Causes Control. 2003;14:497–503.CrossRefPubMed
7.
go back to reference Cui Y, Miller AB, Rohan TE. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat. 2006;100:293–9.CrossRefPubMed Cui Y, Miller AB, Rohan TE. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat. 2006;100:293–9.CrossRefPubMed
8.
go back to reference Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol. 2006;36:387–94.CrossRefPubMed Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol. 2006;36:387–94.CrossRefPubMed
9.
go back to reference Gram IT, Braaten T, Terry PD, Sasco AJ, Adami HO, Lund E, et al. Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomark Prev. 2005;14:61–6. Gram IT, Braaten T, Terry PD, Sasco AJ, Adami HO, Lund E, et al. Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomark Prev. 2005;14:61–6.
10.
go back to reference Fentiman IS, Allen DS, Hamed H. Smoking and prognosis in women with breast cancer. Int J Clin Pract. 2005;59:1051–4.CrossRefPubMed Fentiman IS, Allen DS, Hamed H. Smoking and prognosis in women with breast cancer. Int J Clin Pract. 2005;59:1051–4.CrossRefPubMed
11.
go back to reference Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, et al. Survival of women with breast cancer in relation to smoking. Eur J Surg. 2000;166:852–8.CrossRefPubMed Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, et al. Survival of women with breast cancer in relation to smoking. Eur J Surg. 2000;166:852–8.CrossRefPubMed
12.
go back to reference Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.CrossRefPubMed Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.CrossRefPubMed
13.
go back to reference Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75:569–76.CrossRefPubMed Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75:569–76.CrossRefPubMed
14.
go back to reference Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000;88:674–84.CrossRefPubMed Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000;88:674–84.CrossRefPubMed
15.
go back to reference Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Health behaviors in cancer survivors. Oncol Nurs Forum. 2007;34:643–51.CrossRefPubMed Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Health behaviors in cancer survivors. Oncol Nurs Forum. 2007;34:643–51.CrossRefPubMed
16.
go back to reference Eakin EG, Youlden DR, Baade PD, Lawler SP, Reeves MM, Heyworth JS, et al. Health behaviors of cancer survivors: data from an Australian population-based survey. Cancer Causes Control. 2007;18:881–94.CrossRefPubMed Eakin EG, Youlden DR, Baade PD, Lawler SP, Reeves MM, Heyworth JS, et al. Health behaviors of cancer survivors: data from an Australian population-based survey. Cancer Causes Control. 2007;18:881–94.CrossRefPubMed
17.
go back to reference Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23:8884–93.CrossRefPubMed Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23:8884–93.CrossRefPubMed
18.
go back to reference Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMed Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMed
19.
go back to reference Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40:702–11.CrossRefPubMed Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40:702–11.CrossRefPubMed
20.
go back to reference Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98:632–44.CrossRefPubMed Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98:632–44.CrossRefPubMed
21.
go back to reference Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev. 1997;21:497–509.PubMed Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev. 1997;21:497–509.PubMed
22.
go back to reference Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119:383–90.PubMed Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119:383–90.PubMed
23.
go back to reference Clark TG, Murphy MF, Hey K, Drury M, Cheng KK, Aveyard P. Does smoking influence survival in cancer patients through effects on respiratory and vascular disease? Eur J Cancer Prev. 2006;15:87–90.CrossRefPubMed Clark TG, Murphy MF, Hey K, Drury M, Cheng KK, Aveyard P. Does smoking influence survival in cancer patients through effects on respiratory and vascular disease? Eur J Cancer Prev. 2006;15:87–90.CrossRefPubMed
24.
go back to reference Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int. 2002;90:228–39.CrossRefPubMed Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int. 2002;90:228–39.CrossRefPubMed
25.
go back to reference Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev. 2001;10:823–9. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev. 2001;10:823–9.
26.
go back to reference Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106:17–27.CrossRefPubMed Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106:17–27.CrossRefPubMed
27.
go back to reference Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing. J Clin Oncol. 2005;23:5458–60.CrossRefPubMed Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing. J Clin Oncol. 2005;23:5458–60.CrossRefPubMed
28.
go back to reference Faeh D, Viswanathan B, Chiolero A, Warren W, Bovet P. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health. 2006;6:169.CrossRefPubMed Faeh D, Viswanathan B, Chiolero A, Warren W, Bovet P. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health. 2006;6:169.CrossRefPubMed
29.
go back to reference Tseng TS, Lin HY. Gender and age disparity in health-related behaviors and behavioral patterns based on a National Survey of Taiwan. Int J Behav Med. 2008;15:14–20.CrossRefPubMed Tseng TS, Lin HY. Gender and age disparity in health-related behaviors and behavioral patterns based on a National Survey of Taiwan. Int J Behav Med. 2008;15:14–20.CrossRefPubMed
30.
go back to reference Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, et al. Cigarette smoking and fat distribution in 21, 828 British men and women: a population-based study. Obes Res. 2005;13:1466–75.CrossRefPubMed Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, et al. Cigarette smoking and fat distribution in 21, 828 British men and women: a population-based study. Obes Res. 2005;13:1466–75.CrossRefPubMed
31.
go back to reference Robb CA, Huston SJ, Finke MS. The mitigating influence of time preference on the relation between smoking and BMI scores. Int J Obes (Lond). 2008;32:1670–7.CrossRef Robb CA, Huston SJ, Finke MS. The mitigating influence of time preference on the relation between smoking and BMI scores. Int J Obes (Lond). 2008;32:1670–7.CrossRef
32.
go back to reference Centers for Disease Control and Prevention. (2005). Analytic and reporting guidelines, The National Health and Nutrition Examination Survey (NHANES). National Center for Health Statistics, Centers for Disease Control and Prevention Hyattsville, Maryland. Centers for Disease Control and Prevention. (2005). Analytic and reporting guidelines, The National Health and Nutrition Examination Survey (NHANES). National Center for Health Statistics, Centers for Disease Control and Prevention Hyattsville, Maryland.
34.
go back to reference American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009.
36.
go back to reference Humpel N, Magee C, Jones SC. The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends. Support Care Cancer. 2007;15:621–30.CrossRefPubMed Humpel N, Magee C, Jones SC. The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends. Support Care Cancer. 2007;15:621–30.CrossRefPubMed
Metadata
Title
Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey
Authors
Tung-Sung Tseng
Hui-Yi Lin
Michelle Y. Martin
Ted Chen
Edward E. Partridge
Publication date
01-12-2010
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2010
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0127-9

Other articles of this Issue 4/2010

Journal of Cancer Survivorship 4/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine